Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin
Overview of attention for article published in Journal of Clinical Oncology, July 2007
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
High Attention Score compared to outputs of the same age and source (92nd percentile)
Mentioned by
- policy
- 1 policy source
- 2 X users
- patent
- 3 patents
- guideline
- 3 clinical guideline sources
Readers on
- mendeley
- 147 Mendeley